**Sir,**

We found Dr van Noord\'s preconceptional mitochondrial hypothesis interesting particularly in line with a recent report linking polymorphisms of two DNA base excision repair genes (XRCC1 and hOGG1) to breast cancer risk in daughters born to older mothers ([Hodgson *et al*, 2003](#bib2){ref-type="other"}). Manganese superoxide dismutase (MnSOD) may impair the mitochondria\'s ability to reduce oxidative stress ([Oberley and Oberley, 1997](#bib3){ref-type="other"}). MnSOD has been linked to breast cancer ([Ambrosone *et al*, 1999](#bib1){ref-type="other"}), and may be another pathway through which older maternal age may function. Further support for this hypothesis comes from a recent study that found mitochondrial DNA damage in breast cancer tissue ([Richard *et al*, 2000](#bib4){ref-type="other"}).

To test this hypothesis, we analysed the association of parental age with breast cancer risk using data from the Shanghai Breast Cancer Study (SBCS), and the results are in shown [Table 1](#tbl1){ref-type="table"} Table 1Odds ratios of breast cancer associated with maternal age and paternal age **Cases (*n*=288)Controls (*n*=350)OR^a^(95% CI)OR^b^(95% CI)***Maternal age (years)*       \<2573981.0(referent)1.0(referent) 25--291231271.4(0.8--2.3)1.6(0.9--2.7) 30--3463771.1(0.6--2.0)1.5(0.8--2.9) ⩾3529471.1(0.5--2.2)1.6(0.7--3.9) *P* trend  *P*=0.84 *P*=0.34        *Paternal age (years)*       \<2534411.0(referent)1.0(referent) 25--2996941.4(0.7--2.8)1.3(0.6--2.7) 30--34881031.3(0.7--2.7)1.2(0.6--2.6) ⩾35701110.9(0.4--1.9)0.7(0.3--1.8) *P* trend  *P*=0.13 *P*=0.08 [^1][^2]. After adjustment for established breast cancer risk factors and pregnancy order, we did not find an association between older maternal or paternal age and premenopausal breast cancer in our low-risk population. Additional adjustment for paternal age resulted in a nonsignificantly elevated risk of breast cancer associated with older maternal age. All perinatal information was based on maternal report.

Although we collected information on whether the mother had a threatened miscarriage with the index pregnancy, too few women reported this adverse event (six case mothers, 13 control mothers) to provide a stable risk estimate. Other studies may have sufficient numbers of mothers to investigate this aspect of Dr van Noord\'s hypothesis.

Dr van Noord argued that insulin-like growth factor- I (IGF-1) might be unlikely to explain the inconsistent findings on birth weight and breast cancer risk in the literature, since the link between IGF-I and breast cancer risk has been found primarily in premenopausal women, while the high birth weight-breast cancer association has been seen among pre- and postmenopausal women. A previous report from the SBCS showed that elevated levels of IGF-I were associated with an increased risk of breast cancer among all women, but the association was more pronounced among women diagnosed premenopausally and among women with a high body mass index or waist-to-hip ratio ([Yu *et al*, 2001](#bib6){ref-type="other"}). We found in a large US study that high birth weight was associated with an elevated risk among premenopausal women (OR=1.7, 95% CI 1.1--2.5), but a nonsignificantly reduced risk among postmenopausal women (OR=0.6, 95% CI 0.3--1.1) ([Sanderson *et al*, 1996](#bib5){ref-type="other"}). Therefore, IGF-I as a potential explanation for the birth weight-breast cancer relationship cannot be ruled out.

[^1]: Adjusted for age, income, family history of breast cancer in first-degree relative, history of fibroadenoma, age at menarche, parity, and age at first live birth, and pregnancy order.

[^2]: Adjusted for age, income, family history of breast cancer in first-degree relative, history of fibroadenoma, age at menarche, parity, age at first live birth, pregnancy order, and maternal age or paternal age.
